SayyedHamidiMD

PubMed

• 127 citations
  Moderate Pulmonary Arterial Hypertension in Male Mice Lacking the Vasoactive Intestinal Peptide Gene
  Sami I. Said, Sayyed A. Hamidi, Kathleen G. Dickman, Anthony M. Szema, Sergey Lyubsky
  Circulation. 2007-03-13
• 41 citations
  Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?
  Sami I. Said, Sayyed A. Hamidi, L Gonzalez Bosc
  The European Respiratory Journal. 2010-04-01
• 41 citations
  Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion
  Sayyed A. Hamidi, S Prabhakar, Sami I. Said
  The European Respiratory Journal. 2008-01-01

Books/Book Chapters

• Handbook of Biologically Active Peptides 
  Chapter: VIP 
  Said SI, Hamidi SA, Choppe VEditors: Abba J. Kastin.ElsevierEdition 2nd,2012

Abstracts/Posters

• Denervation alters micro-RNA expression profiles of macrovesicles released by cultured muscle fibers
  Hamidi SA, Rita De Gasperi, Lauren M. Harlow, Hana Ksiezak-Reding, William A. Bauman, and Christopher P. Cardozo, Annual Meeting of Experimental Biology, San Diego, CA, 1/1/2016
• Denervation alters micro-RNA expression profiles of macrovesicles released by cultured muscle fibers
  Hamidi SA, Rita De Gasperi, Lauren M. Harlow, Hana Ksiezak-Reding, William A. Bauman, and Christopher P. Cardozo, The FASEB Journal, 1/1/2016
• Adult onset pica in dialysis patient
  Hamidi SA, Sneha Galiveeti, Adytia Kler, and Ahmed Aziz, Annual Milford Fulop, Poster Competition, Jacobi Medical Center-Albert Einstein COM, NY, 1/1/2015
• Ragweed or Dust Mite Antigen-Stimulated Human Primary Bronchial Epithelial Cells Differentially Express Cytokines In Response To Formoterol Or Mometasone Or Their Comb...
  Anthony Szema, Hamidi SA, Ken-Ichi Takemaru, Marianne Frieri, Journal of Allergy and Clinical Immunology, 1/1/2014
• Decreased IL-4 and TGFa1 in Allergen-Stimulated A549 Cells with Combined Formoterol and Mometasone
  Anthony Szema, Andrea Harrington, Hamidi SA, Marianne Frieri, Journal of Allergy and Clinical Immunology, 1/1/2013
• Further Analysis Of Genotypic-Phenotypic Characterization Of The Heart In VIP Knockout Mice
  Szema AM, Hamidi SA, Smith D, Benveniste H, Am J Respir Crit Care Med, 1/1/2013
• Pharmacogenomics in pulmonary arterial hypertension: toward a mechanistic, target-based approach to therapy
  Hamidi SA and Said SI, ACRT/AFMR/SCTS Joint Annual Conference; Clinical and Translational Research, Washington, DC, 1/1/2012
• Drug combinations for pulmonary hypertension: Selecting drugs that act synergistically, and target multiple pathways
  Hamidi SA, Said SI, International Conference of the American Thoracic Society, San Francisco, 1/1/2012
• VIP and Bosentan: A New More Effective Combination Therapy for Pulmonary Hypertension
  Hamidi SA, Szema AM, Lyubsky S, and Said SI, ACRT/AFMR/SCTS Joint Annual Conference; Clinical and Translational Research, Washington, DC, 1/1/2011
• The VIP gene is a dominant modulator of the pulmonary circulation
  Said SI, Hamidi SA, Proceedings of the American Thoracic Society, 1/1/2011
• A new more effective combination therapy for pulmonary arterial hypertension: Bosentan and VIP
  Hamidi SA, Szema AM, Lyubsky S, Khatami R, and Said SI, Am J Respir Crit Care Med, International Conference of the American Thoracic Society, New Orleans, Louisiana, 1/1/2010
• VIP prevents and reverses monocrotaline-induced PAH: further protection by combination with bosentan
  Hamidi SA, Szema AM, Said SI, Aspen Lung Conference, Colorado, 1/1/2010
• VIP greatly attenuates monocrotaline-induced pulmonary vasculopathy in rats
  Hamidi SA, Szema AM, Said SI, Eur Respir Journal, European Respiratory Society Annual Congress, Vienna, Austria, 1/1/2009
• MCT-induced Pulmoanary Vascular Remodeling and Cor Pulmonale: Prevention by VIP
  Hamidi SA, AM Szema, and SI Said, Am J Respir Crit Care Med, International Conference of the American Thoracic Society, San Diego, CA, 1/1/2009
• VIP greatly attenuates monocrotaline-induced pulmonary vasculopathy in rats
  Hamidi SA, Szema AM, Lyubsky S, and Said SI, Journal of Molecular Neuroscience, 9th International Symposium on VIP, PACAP and Related Peptides, Kagoshima, Japan, 1/1/2009
• A Single Pathogenetic Mechanism for Vascular Remodeling and Inflammation in PAH
  Hamidi SA, Szema AM, and Said SI, Eur Respir Journal, European Respiratory Society Annual Congress, Berlin, Germany, 1/1/2008
• Modulation of Acute Lung Injury by Estrogen Hormone
  Hamidi SA, Berisha HI, Pakbaz H, Dickman KG, Mathew S, and SI Said, Am J Respir Crit Care Med, International Conference of the American Thoracic Society, Toronto, Canada, 1/1/2008
• The VIP Gene is an Essential Modulator of Pulmonary Arterial Hypertension
  Hamidi SA, Prabhakar S, Bhatti AS, and Said SI, Am J Respir Crit Care Med, International Conference of the American Thoracic Society, Toronto, Canada, 1/1/2008
• PAH With Upregulation of Vascular Remodeling and Inflammatory Genes in VIP Knockout Mice
  Hamidi SA, Prabhakar S, and Said SI, Forth World Symposium on Pulmonary Hypertension, Dana Point, CA, 1/1/2008
• VIP is an essential modulator of the pulmonary circulation
  Hamidi SA, Szema AM, Abdel-Razek, TT, Waschek J, and Said SI, 8th International Symposium for VIP, PACAP, Manchester, Vermont, 1/1/2007
• VIP gene deletion triggers gene expression changes promoting pulmonary vascular remodeling
  Hamidi SA, Prabhakar S, and Said SI, 47th Annual Meeting of the American Society for Cell Biology, Washington, DC, 1/1/2007
• In a model of genetic pulmonary hypertension, VIP attenuates pulmonary vascular remodeling and right ventricular hypertrophy
  Hamidi SA, Abdel-Razek TT, Szema AM, and SI. Said, Eur Respir Journal, European Respiratory society Annual Congress, Stokholm, Sweden, 1/1/2007
• Pulmonary Arterial Hypertension in VIP-/- Mice Is Progressive, and Largely Reversible with VIP Treatment
  Hamidi SA, Abdel-Razek TT, Szema AM, Dickman KG, Said SI, Am J Respir Crit Care Med, International Conference of the ATS, San Francisco, 1/1/2007
• Perivascular Inflammation and Vascular Remodeling in a Model of Pulmonary Arterial Hypertension: Coincidence or Cause-and-Effect?
  Hamidi SA, Lyubsky S, Said SI, Am J Respir Crit Care Med, International Conference of the ATS, San Francisco, 1/1/2007
• Gene expression alterations in mice lacking the VIP gene are conducive to PAH and pulmonary vascular remodeling
  Hamidi SA and Said SI, Eur Respir Journal, European Respiratory society Annual Congress, Stokholm, Sweden, 1/1/2007
• Join now to see all

Lectures

• Pharmacogenomics in Pulmonary Arterial Hypertension: Toward a Mechanistic, Target-Based Approach to Therapy 
  Weill medical College of Cornell University, New York, NY - 1/1/2010
• VIP greatly attenuates monocrotaline-induced pulmonary vasculopathy in rats 
  Kagoshima, Japan - 1/1/2009
• VIP attenuates and reverse monocrotaline-induced PAH in rats 
  Vienna, Austria - 1/1/2009
• Perivascular Inflammation and Vascular Remodeling in a Model of P: Coincidence or Cause-and-Effect 
  San Francisco, CA - 1/1/2007
• Pulmonary Arterial Hypertension in VIP KO Mice Is Progressive, and Largely Reversible with VIP Treatment 
  San Francisco, CA - 1/1/2007
• VIP Markedly Attenuates Pulmonary Hypertension in Fawn-Hooded Rats 
  Copenhagen, Denmark - 1/1/2005
• Clues to VIP Function from Knockout Mice 
  Rouen, France - 1/1/2005
• Join now to see all